Fundz

Julier Medical Raises €3 Million In Seed Financing From Sofinnova Partners To Treat Patients With Acute Ischemic Stroke

PRIVATEJan 23, 2023

Amount Raised

€3 Million

Round Type

Seed

ParisBiotechnologyHealth CareMedicalMedical Device

Investors

SofinnovaSofinnova Partners

Description

PARIS, FRANCE / January 23, 2023 / Julier Medical ("Julier"), a Paris-based medical device company developing an innovative solution for the removal of blood clots and post-stroke revascularization, today announced a successful €3 million seed financing from Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan. The funds will support the development of Julier's mechanical thrombectomy device to treat patients with Acute Ischemic Stroke (AIS) until its first clinical study. This is the fifth investment by Sofinnova's medtech acceleration fund, Sofinnova MD Start III.

Quick answer

Julier Medical raised €3 Million in a Seed round, dated January 23, 2023. Investors: Sofinnova and Sofinnova Partners. Julier Medical is based in Paris, Ile-de-France, France.

How much did Julier Medical raise?
Julier Medical raised €3 Million in a Seed round on January 23, 2023.
Who invested in Julier Medical?
Sofinnova and Sofinnova Partners are named as investors in this round.
What does Julier Medical do?
Julier is developing a next generation mechanical thrombectomy solution for the removal of thrombus and revascularization of patients experiencing Acute Ischemic Strokes.
Where is Julier Medical based and how big is it?
Julier Medical is based in Paris, Ile-de-France, France. Fundz records about 6 employees.
Who are the decision-makers at Julier Medical?
Fundz holds 1 contact at Julier Medical, including the Founder, board member. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Julier Medical that raised within 45 days of this round, from Fundz verified event records.

  • Autonomix Medical raised $675K (Seed) on March 6, 2023.
  • SigTuple raised $4.5M (Seed) on March 1, 2023.
  • Rhaeos raised $11M (Series A) on February 16, 2023.
  • Rhaeos raised $6.2M on February 15, 2023.
  • Ostial Corporation raised $7.5M (Series C) on February 8, 2023.
  • Otolith Labs raised $25M on January 23, 2023.

Who to call at Julier Medical, and when

A new round usually means Julier Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Julier Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Julier Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Julier Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Julier Medical

Location

Paris, Ile-de-France, France

About

Julier is developing a next generation mechanical thrombectomy solution for the removal of thrombus and revascularization of patients experiencing Acute Ischemic Strokes. The core technology is derived from the work of two serial medtech entrepreneurs, Laurent Grandidier and Niall Behan.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Julier Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLaurent G., Founder, board member hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Julier Medical's next move

See what Strategic adds

Julier Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.